Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 1, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 2, 2026
10% ownerIndirect holdingOther
Context
Classification
other
Code P in the derivative table; not an open-market share purchase
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000919574-26-006609
Filed / recorded
Oct 2, 2026, 4:35 PM UTC
Added to OQRO
Oct 7, 2026, 2:00 PM UTC
Parser
form4-xml-v2
Data quality
Needs review
Issuer
Pyxis Oncology, Inc.
Issuer CIK
1782223
Ticker
PYXS
Reporting person
GordonMD Global Investments LP
Relationship
10% owner
Security
Common Stock Purchase Warrant
Table
Derivative (Table II)
Transaction date
Oct 1, 2026
Transaction code
P
Shares / units
7,546,766
Acquired / disposed
Acquired (A)
Shares owned after
7,546,766
Ownership form
Indirect — See footnote
Amendment
No
Footnotes from the filing
Exercise price of $3.5, subject to adjustments as set forth in the Common Stock Purchase Warrant.
The combined public offering price for each share of common stock and accompanying Common Stock Purchase Warrant is $2.90.
The Common Stock Purchase Warrant will not be exercisable unless and until (i) the issuer's stockholders approve an amendment to the issuer's amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock (the "Charter Amendment") and (ii) the Charter Amendment is filed with, and becomes effective under the laws of, the State of Delaware (the date on which the Charter Amendment becomes effective, the "Charter Amendment Effective Date").
The Common Stock Purchase Warrant will expire on the earlier of (i) the fifth anniversary of the Charter Amendment Effective Date and (ii) the 30th calendar day following the later of the Charter Amendment Effective Date and the date on which the issuer publicly discloses the results of the overall survival analysis for its Phase 1 monotherapy study of MICVO in second-line and later recurrent or metastatic head and neck squamous cell carcinoma.
The securities to which this filing relates are held directly by GordonMD Long Biased Master Fund LP (the "Master Fund") to which GordonMD Global Investments LP (the "Investment Manager") serves as investment manager. Craig D. Gordon ("Mr. Gordon") is the managing member of GordonMD Long Biased GP LLC (the "GP"), the general partner of the Master Fund. Each of the Master Fund, the GP and Mr. Gordon disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.